Skip to content
All Brands

American Regent, Inc. Issues Voluntary Nationwide

2 recalls on record · Last recall: Sep 3, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
0
Class II — Moderate
0
Class III — Low Risk
0
Unclassified
2

Categories

MEDICATION

Recall Timeline

FDASep 3, 2026

American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility

FOR IMMEDIATE RELEASE – September 3, 2026 – New Albany, OH, American Regent, Inc. is conducting a nationwide voluntary recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vials to the consumer level. Customer complaints were received for leaking and cracked vials, re

FDAJul 27, 2026

American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter

July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an

Track American Regent, Inc. Issues Voluntary Nationwide recalls automatically

Get an alert when a matching American Regent, Inc. Issues Voluntary Nationwide recall turns up.

Start Free Trial